Loading clinical trials...
Loading clinical trials...
The De-novo Use of Eculizumab Alongside Conventional Therapy in Presensitized Patients Receiving Cardiac Transplantation: An Open-Label, Investigator-Initiated Pilot Trial: [The DUET Cardiac Trial]
Conditions
Interventions
Eculizumab
Locations
1
United States
Cedars Sinai Medical Center, Heart Institute
Los Angeles, California, United States
Start Date
November 1, 2012
Primary Completion Date
December 30, 2019
Completion Date
April 30, 2020
Last Updated
May 3, 2021
NCT05208567
NCT05764057
NCT05189860
NCT05004493
NCT04561986
NCT06088212
Lead Sponsor
Cedars-Sinai Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions